Compare LAMR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAMR | SNN |
|---|---|---|
| Founded | 1902 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 14.0B |
| IPO Year | 1996 | 1999 |
| Metric | LAMR | SNN |
|---|---|---|
| Price | $133.20 | $33.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $131.75 | $32.83 |
| AVG Volume (30 Days) | ★ 496.4K | 476.9K |
| Earning Date | 11-06-2025 | 03-02-2026 |
| Dividend Yield | ★ 4.67% | 2.19% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 4.24 | 0.56 |
| Revenue | $2,253,062,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $4.38 | $7.78 |
| Revenue Next Year | $4.46 | $5.13 |
| P/E Ratio | $31.32 | ★ $29.10 |
| Revenue Growth | 2.98 | ★ 5.35 |
| 52 Week Low | $99.84 | $23.69 |
| 52 Week High | $134.63 | $38.79 |
| Indicator | LAMR | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 65.90 | 48.01 |
| Support Level | $130.56 | $32.68 |
| Resistance Level | $133.26 | $33.56 |
| Average True Range (ATR) | 2.45 | 0.41 |
| MACD | 0.07 | 0.14 |
| Stochastic Oscillator | 79.83 | 78.51 |
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.